Chest computed tomography scan findings of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis

被引:10
作者
Karimian, Mohammad [1 ]
Azami, Milad [2 ]
机构
[1] Ilam Univ Med Sci, Fac Med, Dept Gen Surg, Ilam, Iran
[2] Ilam Univ Med Sci, Fac Med, Ilam, Iran
关键词
computed tomography; COVID-19; meta-analysis; ACUTE RESPIRATORY SYNDROME; CT FINDINGS; CLINICAL CHARACTERISTICS; INFLUENZA-A; PNEUMONIA; WUHAN; EVOLUTION; FEATURES;
D O I
10.5114/pjr.2021.103379
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Numerous cases of pneumonia caused by coronavirus disease 2019 (COVID-19) were reported in Wuhan, China. Chest computed tomography (CT) scan is highly important in the diagnosis and follow-up of lung disease treatment. The present meta-analysis was performed to evaluate chest CT scan findings in COVID-19 patients. Material and methods: All research steps were taken according to the Meta-Analysis of Observational Studies In Epidemiology (MOOSE) protocol and the final report was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We registered this review at the International Prospective Register of Systematic Reviews (PROSPERO, CRD42019127858). Results: Forty eligible studies including 4598 patients with COVID-19 were used for meta-analysis. The rate of positive chest CT scan in patients with COVID-19 was 94.5% (95% CI: 91.7-96.3). Bilateral lung involvement, pure ground-glass opacity (GGO), mixed (GGO pulse consolidation or reticular), consolidation, reticular, and presence of nodule findings in chest CT scan of COVID-19 pneumonia patients were respectively estimated to be 79.1% (95% CI: 70.8-85.5), 64.9% (95% CI: 54.1-74.4), 49.2% (95% CI: 35.7-62.8), 30.3% (95% CI: 19.6-43.6), 17.0% (95% CI: 3.9-50.9) and 16.6% (95% CI: 13.6-20.2). The distribution of lung lesions in patients with COVID-19 pneumonia was peripheral (70.0% [95% CI: 57.8-79.9]), central (3.9% [95% CI: 1.4-10.6]), and peripheral and central (31.1% [95% CI: 19.5-45.81). The pulmonary lobes most commonly involved were the right lower lobe (86.5% [95% CI: 57.7-96.8]) and left lower lobe (81.0% [95% CI: 50.5-94.7]). Conclusions: The most important outcomes in chest CT scan of patients with COVID-19 pneumonia were bilateral lung involvement, GGO or mixed (GGO pulse consolidation or reticular) patterns, thickened interlobular septa, vascular enlargement, air bronchogram sign, peripheral distribution, and left and right lower lobes involvement. Our study showed that chest CT scan has high sensitivity in the diagnosis of COVID-19, and may therefore serve as a standard method for diagnosis of COVID-19.
引用
收藏
页码:E31 / E49
页数:19
相关论文
共 50 条
[41]   Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis [J].
Praveen Kumar-M ;
Shubhra Mishra ;
Daya Krishna Jha ;
Jayendra Shukla ;
Arup Choudhury ;
Ritin Mohindra ;
Harshal S. Mandavdhare ;
Usha Dutta ;
Vishal Sharma .
Hepatology International, 2020, 14 :711-722
[42]   A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19) [J].
Danwang, Celestin ;
Endomba, Francky Teddy ;
Nkeck, Jan Rene ;
Wouna, Dominic Leandry Angong ;
Robert, Annie ;
Noubiap, Jean Jacques .
BIOMARKER RESEARCH, 2020, 8 (01)
[43]   Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients [J].
Islam, Md Asiful ;
Alam, Sayeda Sadia ;
Kundu, Shoumik ;
Hossan, Tareq ;
Kamal, Mohammad Amjad ;
Cavestro, Cinzia .
FRONTIERS IN NEUROLOGY, 2020, 11
[44]   Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis [J].
Lippi, Giuseppe ;
Plebani, Mario .
CLINICA CHIMICA ACTA, 2020, 505 :190-191
[45]   The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis [J].
Akbari, Hamed ;
Tabrizi, Reza ;
Lankarani, Kamran B. ;
Aria, Hamid ;
Vakili, Sina ;
Asadian, Fatemeh ;
Noroozi, Saam ;
Keshavarz, Pedram ;
Faramarz, Sanaz .
LIFE SCIENCES, 2020, 258
[46]   Comprehensive review of coronavirus disease 2019 (COVID-19) [J].
Chauhan, Shaylika .
BIOMEDICAL JOURNAL, 2020, 43 (04) :334-340
[47]   Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis [J].
Abate, Biruk Beletew ;
Kassie, Ayelign Mengesha ;
Kassaw, Mesfin Wudu ;
Aragie, Teshome Gebremeskel ;
Masresha, Setamlak Adane .
BMJ OPEN, 2020, 10 (10)
[48]   Neuroimaging Findings in Patients with COVID-19: A Systematic Review and Meta-Analysis [J].
Kim, Pyeong Hwa ;
Kim, Minjae ;
Suh, Chong Hyun ;
Chung, Sae Rom ;
Park, Ji Eun ;
Kim, Soo Chin ;
Choi, Young Jun ;
Lee, Jeong Hyun ;
Kim, Ho Sung ;
Baek, Jung Hwan ;
Choi, Choong Gon ;
Kim, Sang Joon .
KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (11) :1875-1885
[49]   Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis [J].
Yamada, Takayuki ;
Wakabayashi, Mako ;
Yamaji, Takahiro ;
Chopra, Nitin ;
Mikami, Takahisa ;
Miyashita, Hirotaka ;
Miyashita, Satoshi .
CLINICA CHIMICA ACTA, 2020, 509 :235-243
[50]   Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis [J].
Ahmed Yassin ;
Mohammed Nawaiseh ;
Ala Shaban ;
Khalid Alsherbini ;
Khalid El-Salem ;
Ola Soudah ;
Mohammad Abu-Rub .
BMC Neurology, 21